Masitinib for the treatment of mild to moderate Alzheimer's disease

Review

Abstract: Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of de

Palabras claves:

ALZHÉIMER, inflammation, masitinib, Neurodegeneration, Tau

Autores:

Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Lazarowski A., Miguel Marin, Olloquequi J., Pedros I., Petrov D., Zárate C.B.

Fuentes:

scopus